These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7147 related items for PubMed ID: 1914078

  • 1. Antitumor activity on murine tumors of a novel antitumor benzoylphenylurea derivative, HO-221.
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Fujimoto S, Tsukagoshi S, Taguchi T.
    Cancer Chemother Pharmacol; 1991; 28(5):351-6. PubMed ID: 1914078
    [Abstract] [Full Text] [Related]

  • 2. [Cross-resistance of HO-221 and various antitumor agents in sublines of mouse leukemia].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Fujimoto S, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):201-9. PubMed ID: 1899547
    [Abstract] [Full Text] [Related]

  • 3. [Antitumor effect of a benzoylphenylurea derivative HO-221].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871
    [Abstract] [Full Text] [Related]

  • 4. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S, Ogawa M.
    Cancer Chemother Pharmacol; 1982 Apr; 8(2):157-62. PubMed ID: 7105379
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
    Shimomura K, Manda T, Mukumoto S, Masuda K, Nakamura T, Mizota T, Matsumoto S, Nishigaki F, Oku T, Mori J.
    Cancer Res; 1988 Mar 01; 48(5):1166-72. PubMed ID: 3342397
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
    Kobayashi M, Natsume T, Tamaoki S, Watanabe J, Asano H, Mikami T, Miyasaka K, Miyazaki K, Gondo M, Sakakibara K, Tsukagoshi S.
    Jpn J Cancer Res; 1997 Mar 01; 88(3):316-27. PubMed ID: 9140117
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K, Oka T, Morimoto M.
    Cancer Res; 1987 Mar 15; 47(6):1516-22. PubMed ID: 2434218
    [Abstract] [Full Text] [Related]

  • 9. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
    Nishikawa K, Shibasaki C, Hiratsuka M, Arakawa M, Takahashi K, Takeuchi T.
    J Antibiot (Tokyo); 1991 Oct 15; 44(10):1101-9. PubMed ID: 1955393
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
    Waud WR, Plowman J, Harrison SD, Dykes DJ, Anderson WK, Griswold DP.
    Cancer Chemother Pharmacol; 1992 Oct 15; 30(4):261-6. PubMed ID: 1322803
    [Abstract] [Full Text] [Related]

  • 11. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice.
    Ueda H, Manda T, Matsumoto S, Mukumoto S, Nishigaki F, Kawamura I, Shimomura K.
    J Antibiot (Tokyo); 1994 Mar 15; 47(3):315-23. PubMed ID: 8175484
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.
    Bissery MC, Nguyen CH, Bisagni E, Vrignaud P, Lavelle F.
    Invest New Drugs; 1993 Nov 15; 11(4):263-77. PubMed ID: 8157469
    [Abstract] [Full Text] [Related]

  • 13. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 14. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo.
    Harrison SD, Plowman J, Dykes DJ, Waud WR, Griswold DP.
    Cancer Chemother Pharmacol; 1990 Oct 15; 25(6):425-9. PubMed ID: 2311170
    [Abstract] [Full Text] [Related]

  • 15. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G.
    Cancer Chemother Pharmacol; 1996 Oct 15; 38(6):513-21. PubMed ID: 8823492
    [Abstract] [Full Text] [Related]

  • 16. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
    Fujita F, Fujita M, Inaba H, Sugimoto T, Okuyama Y, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Oct 15; 18(13):2263-70. PubMed ID: 1929447
    [Abstract] [Full Text] [Related]

  • 17. [Mechanism of antitumor effect of a benzoylphenylurea derivative, HO-221].
    Nakajima T, Okamoto T, Masuda H, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1990 Dec 15; 17(12):2345-51. PubMed ID: 2260870
    [Abstract] [Full Text] [Related]

  • 18. FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome.
    Naoe Y, Inami M, Matsumoto S, Nishigaki F, Tsujimoto S, Kawamura I, Miyayasu K, Manda T, Shimomura K.
    Cancer Chemother Pharmacol; 1998 Dec 15; 42(1):31-6. PubMed ID: 9619755
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
    Morimoto M, Ashizawa T, Ohno H, Azuma M, Kobayashi E, Okabe M, Gomi K, Kono M, Saitoh Y, Kanda Y.
    Cancer Res; 1991 Jan 01; 51(1):110-5. PubMed ID: 1988076
    [Abstract] [Full Text] [Related]

  • 20. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
    Bissery MC, Vrignaud P, Lavelle F, Chabot GG.
    Anticancer Drugs; 1996 Jun 01; 7(4):437-60. PubMed ID: 8826613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 358.